Arcadia Biosciences Inc
RKDA
Get informed when a big investor buys or sells
+ FollowMarket Cap$708.05K
Close$
$5.03
1094.8% upside
Current Fair Value
1094.8% upsideUndervalued by 1094.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $708,052.00 |
|---|---|
| Enterprise Value | $-3,469,948.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.71 |
| Beta | 0.55 |
| Outstanding Shares | 2,540,234 |
Return
| Return on Equity | -1758.45% |
|---|---|
| Return on Assets | -188.89% |
| Return on Invested Capital | 93.62% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.2 |
| Price to Sales | 0.42 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.73 |
| Enterprise Value to EBIT | -0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$2.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.54%▲ 22.68% |
|---|---|
| Total Invested | $482,143▲ 522.57% |
| Investors Holding | 15▲ 2.00% |
ESG Score
No data